Tempus AI, Inc.
TEMHealthcareNASDAQHealth Information Services
Scan Results
Daily timeframeTempus AI, Inc. operates as a healthcare technology company in the United States. The company carries a $12.32B market cap, placing it firmly in the large-cap category. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.
Market Cap
$12.32B
Beta
3.54
P/E (TTM)
—
P/E (Fwd)
-1435.26
EPS (TTM)
$-1.44
EPS (Fwd)
$-0.05
ROE
-67.4%
ROA
-8.8%
Cash
$816.0M
Total Debt
$1.44B
Free CF
-$99.2M
52W Change
-26.2%
Annual Financials
Cash vs Debt
Where TEM stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, TEM finished 14.73% above its 150-day moving average ($56.08) and 13.25% above its 200-day moving average ($56.81). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is TEM overbought or oversold?
At the October 20, 2026 close, TEM's RSI(14) was 28.2, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, TEM has $816.0M in cash with $1.44B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company is burning cash, with free cash flow at -$99.2M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. ROE of -67.4% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $320.7M (2022) to $1.27B (2025), reflecting a 297% increase over the period.
Tempus AI, Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Tempus AI, Inc. and its sector.